Menu

Blog

Mar 19, 2024

Circulating tumor DNA levels predict outcomes for gastroesophageal cancer treated with immunotherapy

Posted by in categories: biotech/medical, futurism

Monitoring levels of DNA shed by tumors and circulating in the bloodstream could help doctors accurately assess how gastroesophageal cancers are responding to treatment, and potentially predict future prognosis, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg–Kimmel Institute for Cancer Immunotherapy.

Comments are closed.